Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00069095
Brief Title: A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer

First Submitted : September 15, 2003
First Submitted that Met QC Criteria : September 17, 2003
First Posted : September 18, 2003 (Estimate)

Results First Submitted : December 11, 2015
Results First Submitted that Met QC Criteria : December 11, 2015
Results First Posted : January 22, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 26, 2016
Last Update Posted : October 6, 2016 (Estimate)